-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/primary-open-angle-glaucoma-screening
June 04, 2020 - Abbreviation: KQ = Key Question. … Contextual Question
Contextual
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
September 05, 2019 - Questions
The contextual question … renal disease to the list of cardiovascular disease risk factors to be reviewed for the contextual question
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/glaucoma-october-2022
August 13, 2021 - Abbreviation: KQ = Key Question. … Contextual Question
Contextual questions will not be systematically reviewed and are not shown
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/glaucoma-screening-adults-older-adults
August 13, 2021 - Abbreviation: KQ = Key Question. … Contextual Question
Contextual questions will not be systematically reviewed and are not shown
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/primary-angle-glaucoma-screening
August 13, 2021 - Abbreviation: KQ = Key Question. … Contextual Question
Contextual questions will not be systematically reviewed and are not shown
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/qguycZWFxAQfzsJJFwEn23
January 25, 2022 - Key Question 1a. … Detection of AF
Key Question 2. … Key Question 4a. … Key Question 5a. … Key Question 6a.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/BhnZRA--TRpXdg9_tYmZ_M
April 05, 2016 - KQ indicates key question.
a Details about reasons for exclusion are as follows. … Range of Diagnostic Accuracy Values for FEV1/FEV6 in Included Studies (Key Question 3)
Source
No. … Study Characteristics and Abstinence Outcomes of Smoking Cessation Trials (Key Question 5a)
Source
No … Summary of Findings: Treatment Efficacy (Key Question 7)
LABA ICS LABA-ICS LAMA Tiotropium
Population … Summary of Evidence Table (continued)
Key Question Population No. of Studies
No. of
Participants Study
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan13/dental-caries-in-children-from-birth-through-age-5-years-screening
December 15, 2012 - Question to Be Contextually Reviewed (Not Systematically Reviewed)
IV. … Question to Be Contextually Reviewed (Not Systematically Reviewed)
What percentage of young
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan13/dental-caries-in-children-from-birth-through-age-5-years-screening-2014
December 15, 2012 - Question to Be Contextually Reviewed (Not Systematically Reviewed)
IV. … Question to Be Contextually Reviewed (Not Systematically Reviewed)
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/sexually-transmitted-infections-behavioral-counseling-september-2014
September 22, 2014 - 1), behavioral outcomes (key question 2), other positive outcomes (key question 3), and harms of counseling … (key question 4). … The following number of article were included for Key Question 1 (n=41), Key Question 2 (n=46), Key Question … 3 (n=15), and Key Question 4 (n=4).
… KQ = key question; STI = sexually transmitted infection.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
May 16, 2024 - Alcohol, and other Drugs (BSTAD) or comparable
Studies without any screening instruments or question … to design-specific USPSTF criteria)
Abbreviations: DUI=driving under the influence; KQ=key question … In response to public comments, we added an additional contextual question to examine the barriers and
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZcuLSXJZXLz9Y2LECTWqVJ
November 01, 2009 - Harms Associated With Mammography Screening (Key
Question 2a)
Radiation Exposure
No studies directly … Harms associated with mammography
screening (key question 2a)
Several systematic reviews and
primary … Clinical breast examination screening
benefits (key question 1b)
1 (2 in progress) RCT The trial was … 1b:
CBE
outcomes
2 trials +
3 SRs
Key question 1c:
BSE
outcomes
Radiation: 5 studies + 1 SR
Pain … 2a:
mammography
harms
3 studies
Key question 2b:
CBE
harms
3 studies
Key question 2c:
BSE
harms
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary45/skin-cancer-counseling-2012
May 15, 2012 - Search Strategies for Each Question Based on Existing Systematic Reviews
Table 2. … Inclusion and Exclusion Criteria, by Key Question
Appendix Table 2. … Key question 5: Are sun-protective behaviors associated with adverse effects? … (35 unique studies) for key question 4, and 19 articles (17 unique studies) for key question 5. … Search Strategies for Each Question Based on Existing Systematic Reviews
Key Question
Skin
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
October 22, 2015 - Abbreviation: KQ = key question … The USPSTF also revised a key question to clarify that subgroup analyses based on timing of initiation
-
www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-appendix-v-work-planresearch-plan-template
July 01, 2017 - Previous Review Findings
Insert summary of evidence table with overall quality assessment for each key question … What study designs (types of designs and comparisons) are minimally acceptable for evaluating each key question … What settings (timeframes, countries, populations) are minimally acceptable for evaluating each key question … Search Criteria
Include databases and time periods for each key question, as well as search terms for
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-v-work-planresearch-plan-template
July 01, 2017 - Previous Review Findings
Insert summary of evidence table with overall quality assessment for each key question … What study designs (types of designs and comparisons) are minimally acceptable for evaluating each key question … What settings (timeframes, countries, populations) are minimally acceptable for evaluating each key question … Search Criteria
Include databases and time periods for each key question, as well as search terms for
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan93/impaired-visual-acuity-in-older-adults-screening
September 27, 2014 - Contextual Question
Contextual questions will not be systematically reviewed and are not shown … vision screening with no screening
KQ 3: Studies evaluating diagnostic accuracy of a screening question
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
November 01, 2021 - Prospective Diagnostic Accuracy Studies of Screening Computed Tomographic Colonography (Key Question … Key Question 3b. Do adverse effects vary by important subpopu-
lations (eg, age)? … Perforations From Flexible Sigmoidoscopy (Key Question 3)
0 50 7525
Event Rate per 10 000 Procedures … Major Bleeding From Flexible Sigmoidoscopy (Key Question 3)
0
Event Rate per 10 000 Procedures (95% … Key question 3b: Do adverse effects
vary by important subpopulations (eg, age)?
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening
June 15, 2016 - Key Question 3b. Do adverse effects vary by important subpopulations (eg, age)? … for key question 3. … Prospective Diagnostic Accuracy Studies of Screening Computed Tomographic Colonography (Key Question … Summary of Evidence by Key Question and Screening Test
Test Name
Study Design
No. … Key question 3b: Do adverse effects vary by important subpopulations (eg, age)?
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
June 15, 2016 - Key Question 3b. Do adverse effects vary by important subpopulations (eg, age)? … for key question 3. … Prospective Diagnostic Accuracy Studies of Screening Computed Tomographic Colonography (Key Question … Fair to good
Key Question 2: Diagnostic Accuracy of Screening c
Colonoscopy
Prospective … Key question 3b: Do adverse effects vary by important subpopulations (eg, age)?